Literature DB >> 6869815

Preparation and properties of fluorescent polysaccharides.

C G Glabe, P K Harty, S D Rosen.   

Abstract

A new method for preparing fluorescein derivatives of polysaccharides is described. These derivatives are prepared by activation of the polysaccharide with cyanogen bromide and subsequent reaction with fluoresceinamine. The optimum conditions for coupling have been established in this report. Using this procedure, we have prepared fluorescein derivatives of a wide variety of polysaccharides. Degrees of substitution in the range of 3.0 X 10(-3) to 2.4 X 10(-2) mol of fluorescein per mole of monosaccharide equivalent were obtained. The fluorescent derivatives are stable: no free fluorescein was detected after incubation at 22 degrees C for 48 h or at -10 degrees C for 4 months. The fluorescein-derivatized polysaccharides were found to have the same potency in inhibiting lectin-mediated hemagglutination as the underivatized polysaccharide. In addition, these fluorescent polysaccharides can be radioiodinated to specific activities exceeding 10(6) dpm/micrograms due to incorporation of 125I into fluorescein. The cell binding properties of 125I-fucoidin and 125I-heparin are indistinguishable from the corresponding underivatized polysaccharides. This general approach for preparing fluorescent polysaccharides should produce useful reagents for localizing and quantifying cell surface carbohydrate-binding proteins (lectins).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869815     DOI: 10.1016/0003-2697(83)90590-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  29 in total

1.  Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.

Authors:  Steve Bourgault; James P Solomon; Natàlia Reixach; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

2.  Interaction of heparin with fibronectin and isolated fibronectin domains.

Authors:  K C Ingham; S A Brew; D H Atha
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

3.  Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.

Authors:  S Ohkuma; T Sato; M Okamoto; H Matsuya; K Arai; T Kataoka; K Nagai; H H Wasserman
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin.

Authors:  S Gustafson; T Björkman
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

5.  Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension.

Authors:  James P Solomon; Steve Bourgault; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-03-15       Impact factor: 3.162

6.  Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H(+)-ATPase.

Authors:  S Ohkuma; S Shimizu; M Noto; Y Sai; K Kinoshita; H Tamura
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

7.  Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex.

Authors:  R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

Review 8.  Proteoglycans and cell adhesion. Their putative role during tumorigenesis.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Labelling of high molecular weight hyaluronan with 125I-tyrosine: studies in vitro and in vivo in the rat.

Authors:  S Gustafson; T Björkman; J E Westlin
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

10.  Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.

Authors:  M K Lee; A D Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.